Phylogenetic analysis confirms hepatitis C virus transmission among hemodialysis patients in Kosovo.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
31 12 2019
Historique:
received: 13 10 2019
accepted: 04 11 2019
entrez: 24 2 2020
pubmed: 24 2 2020
medline: 25 7 2020
Statut: epublish

Résumé

It has recently been demonstrated that there is a very high prevalence of hepatitis C virus (HCV) infection among hemodialysis patients in Kosovo with HCV subtype 1 being the most prevalent subtype. In this study, we further detail the molecular epidemiology of HCV outbreaks occurring in seven dialysis centers in Kosovo. In total, 273 samples obtained from HCV RNA positive patients undergoing hemodialysis at one of the seven centers in Kosovo were selected for this study: 171 subtype 1a samples, 91 subtype 4d samples, and 11 subtype 1b samples. A partial HCV NS5B region was amplified and sequenced. Subtype-specific phylogenetic analyses were performed with the inclusion of control sequences and transmission clusters were identified. NS5B sequences were successfully obtained in 257/273 (94.1%) of samples; 162 subtype 1a, 84 subtype 4d, and 11 subtype 1b sequences. Phylogenetic analyses showed a high degree of phylogenetic clustering of HCV sequences subtyped 1a (99.4%), 1b (63.6%), and 4d (76.2%). Distinct phylogenetic clusters of sequences obtained from hemodialysis patients were observed for all three subtypes studied. In addition, several smaller clusters within the large clusters were identified, mainly from a single dialysis center. Phylogenetic analyses confirmed nosocomial transmission during dialysis as a major factor in the spread of HCV at the seven dialysis centers in Kosovo.

Identifiants

pubmed: 32088702
doi: 10.3855/jidc.12099
doi:

Substances chimiques

Viral Nonstructural Proteins 0
NS-5 protein, hepatitis C virus EC 2.7.7.48

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1142-1149

Informations de copyright

Copyright (c) 2019 Xhevat Jakupi, Jana Mlakar, Maja Lunar, Ibrahim Rudhani, Lul Raka, Norma Tavakoli, Mario Poljak".

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Xhevat Jakupi (X)

Department of Microbiology, National Institute of Public Health of Kosovo, Prishtina, Kosovo. xhevat.r.jakupi@rks-gov.net.

Jana Mlakar (J)

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. jana.mlakar@mf.uni-lj.si.

Maja Lunar (M)

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. maja.lunar@mf.uni-lj.si.

Ibrahim Rudhani (I)

Faculty of Medicine, University of Prishtina "Hasan Prishtina", Prishtina, Kosovo. ibrahim.rudhani@uni-pr.edu.

Lul Raka (L)

Faculty of Medicine, University of Prishtina "Hasan Prishtina", Prishtina, Kosovo. lul.raka@uni-pr.edu.

Norma Tavakoli (N)

Division of Genetics, Wadsworth Center, New York State Department of Health, Albany, New York, United States. norma.tavakoli@health.ny.gov.

Mario Poljak (M)

Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. mario.poljak@mf.uni-lj.si.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH